Global Health Investment Corporation — 2026 Investments
2 investments dated 2026 · listed companies and verified rows first · show all
Antheia uses a yeast-based biosynthesis and fermentation platform to manufacture Key Starting Materials (KSMs) and Active Pharmaceutical Ingredients (APIs) for essential medicines, offering an alternative to fragile agricultural sourcing.
Advanced ManufacturingBiotechHealthtechMenlo Park, US
Christina Smolke(Founder)inKristy Hawkins(Founder)inEric d'Esparbes(Chief Financial Officer)inZack McGahey(Chief Operating Officer)inHeidi Pucel(Chief People Officer)in
BoardRam Shriram(Director)
Co-investorsAmerica's Frontier FundCivilization Ventures Management, LlcIn-Q-TelLam CapitalSherpalo VenturesWestern Technology Investment
Prenosis develops AI-powered precision medicine diagnostics for acute care, built on its Immunix platform and a biobank of clinical data for infection.
AI & Machine LearningDigital HealthHealthtechMedical Devices
Co-investorsPACE Healthcare Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.











